Islam Md Shoriful, Agarwala Rashni, Khatun Sozoni, Enam Tonima, Siddika Ayesha, Saffat Tasfia, Jahan Mst Israt, Shimki Afia Ibnath, Akter Azifa, Snigdha Mahajabin, Tasmin Rubaia
Department of Pharmacy Islamic University Kushtia Bangladesh.
Health Sci Rep. 2025 Aug 19;8(8):e71188. doi: 10.1002/hsr2.71188. eCollection 2025 Aug.
Acute gastritis affects roughly 8 out of every 1000 people, while chronic gastritis affects about 2 out of every 10,000 people worldwide. When something destroys or affects the mucosa lining the stomach, which protects it from the powerful stomach acid that breaks down food, the mucosa becomes inflamed, causing gastritis. A questionnaire-based survey was designed to assess the epidemiology of gastritis based on the patient's symptomatology and potential causes of these symptoms, severity, current epidemiology, treatment, and assessment of the health-related quality of life with response to treatment and medication awareness of gastritis-related diseases in Bangladesh.
A self-reported, cross-sectional study of 1051 gastric patients (57% male and 43% female) was conducted in Bangladesh using a simple random selection method with descriptive demographic and clinical characteristic statistics. Based on the availability of high-quality data, we worked on several governmental and nongovernmental hospitals and clinics in eight randomly selected districts around the country.
With an 87.58% response rate (603 men and 448 females), 81% of participants were actual gastric patients, and the remaining 19% took gastric medicines with other medications for various diseases. Patients between the ages of 31 and 60 were the most likely to suffer from gastritis, where males are significantly more represented than females. A sedentary lifestyle (45%, = 478) and obesity (28%, = 294) are the most common causes, while regurgitation (64%, = 677) and stomach bloating (58%, = 609) are the most common symptoms. Surprisingly, 51% of patients were taking self-medication, mostly (79.1%, = 831) proton pump inhibitors (PPIs), a class of medications that come in solid dosage forms (capsule 63% and tablet 33%).
This survey revealed the prevalence of gastritis and functional gastrointestinal disorders (FGIDs) in Bangladesh for the first time. The insight of this study will contribute to a better understanding of the current causes, epidemiology, diagnosis, symptoms, and treatment of gastritis in Bangladesh.
在全球范围内，每1000人中约有8人会患急性胃炎，而每10000人中约有2人会患慢性胃炎。当胃黏膜（胃黏膜可保护胃免受分解食物的强胃酸侵蚀）遭到破坏或受到影响时，胃黏膜就会发炎，进而引发胃炎。我们设计了一项基于问卷调查的研究，旨在根据患者的症状、这些症状的潜在病因、严重程度、当前流行病学情况、治疗方法以及对治疗的反应所带来的与健康相关的生活质量评估，来评估孟加拉国胃炎的流行病学情况以及患者对胃炎相关疾病的用药认知。
在孟加拉国，我们采用简单随机抽样方法，对1051名胃病患者（男性占57%，女性占43%）进行了一项自我报告的横断面研究，并对描述性人口统计学和临床特征进行了统计。基于高质量数据的可得性，我们在该国随机选取的八个地区的多家政府和非政府医院及诊所开展了研究。
回应率为87.58%（男性603人，女性448人），其中81%的参与者为实际胃病患者，其余19%的参与者因患有其他各种疾病而在服用胃药的同时还服用了其他药物。年龄在31岁至60岁之间的患者最容易患胃炎，其中男性的占比明显高于女性。久坐不动的生活方式（45%，即478人）和肥胖（28%，即294人）是最常见的病因，而反流（64%，即677人）和胃胀（58%，即609人）是最常见的症状。令人惊讶的是，51%的患者在自行用药，其中大部分（79.1%，即831人）使用的是质子泵抑制剂（PPIs），这是一类固体剂型的药物（胶囊占63%，片剂占33%）。
本次调查首次揭示了孟加拉国胃炎和功能性胃肠疾病（FGIDs）的患病率。这项研究的深入分析将有助于更好地了解孟加拉国当前胃炎的病因、流行病学情况、诊断方法、症状及治疗手段。
